雜志介紹

Cardiology And Therapy雜志介紹

《Cardiology And Therapy》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱心臟病學(xué)和治療，本刊主要出版、報道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3，最新CiteScore 指數(shù)為5.3。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Emerging PET Tracers in Cardiac Molecular Imaging

  Author: Singh, Shashi Bhushan; Ng, Sze Jia; Lau, Hui Chong; Khanal, Kishor; Bhattarai, Sanket; Paudyal, Pranita; Shrestha, Bimash Babu; Naseer, Rizwan; Sandhu, Simran; Gokhale, Saket; Raynor, William Y. Y.

• Application of Single-Cell Genomics in Cardiovascular Research

  Author: Yu, Xuejing; Yang, Xianggui; Cao, Jinjin

• Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation

  Author: Patti, Giuseppe; Wang, Rosa; Marston, Xiaocong Li; Yeh, Yu-Chen; Zimmermann, Lisa; Ye, Xin; Gao, Xin; Brueggenjuergen, Bernd

• Efficacy and Safety of Evolocumab in Chinese Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia: 12-Week Primary Results of the HUA TUO (sic) Randomized Clinical Trial

  Author: Tan, Hong; Li, Weimin; Huang, Zhouqing; Han, Yajun; Huang, Xuecheng; Li, Dongye; Xing, Xiaochun; Monsalvo, Maria Laura; Wu, You; Mao, Jackie; Xin, Lily; Chen, Jiyan

英文介紹

Cardiology And Therapy雜志英文介紹

Cardiology And Therapy strives to be the leading publishing platform for innovative research results in the field of cardiovascular medicine. The goal of the journal is to facilitate the exchange of knowledge among medical professionals and researchers worldwide and to accelerate the development and application of cardiovascular therapies and interventions. The types of research the journal encourages range from initial basic science studies to late-stage clinical trials to long-term observational studies of patient outcomes.

Journals evaluate the safety and effectiveness of new drugs, devices or treatments at different stages. The risk factors and natural course of cardiovascular disease were explored through cohort studies and case-control studies. Use real-world data to evaluate the effectiveness of medical interventions in actual clinical practice. Focus on the patient's health status after treatment, including quality of life, functional status, and long-term prognosis. To analyze the cost-effectiveness of treatment methods for cardiovascular diseases, and to provide basis for rational allocation of medical resources.